NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/03/2026
Back to search
Official data from USPTO
MEDLIOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
88
Latest update
02/04/2026
Trademark type
Word
Nice classes
35, 42
Filing date
02/19/2020
Registration date
02/03/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/03/2026
Last transaction
02/04/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
First use anywhere
2018-00-00
First use in commerce
2018-00-00
Drawing code
4
Owner type
03
Owner location
Calgary, AB, CA
Examiner
SWIFT, GILBERT M
Law office
L90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Medlior Health Outcomes Research Ltd.
Representatives
Michael J Leonard Fox Rothschild LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting servicesdeveloping research proposals and analytical plans for the healthinsurancemedical industries
Class 42
Medical research services featuring an online listing of patient datasets for purposes of health research; medical research services featuring de-identified patient datasets to consumers for purposes of health research; providing medical and scientific research information in the field of life sciences; life sciences research; technical writing; medical research services featuring statistical analysis and reporting services for health research; medical research services featuring statistical evaluation of data from de-identified patient information; medical research consulting servicesdeveloping research proposals and analytical plans for consumers in the healthinsurance and medical industries
Publications
History of USPTO decisions and trademark events.
88 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/16/2025
PUBO
PUBLISHED FOR OPPOSITION
12/16/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/17/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/22/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/22/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/22/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/22/2025
GNFR
FINAL REFUSAL E-MAILED
06/22/2025
CNFR
FINAL REFUSAL WRITTEN
06/22/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/12/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/08/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/27/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/27/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/27/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/27/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
03/17/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
03/17/2025
CNSI
SUSPENSION INQUIRY WRITTEN
03/17/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/12/2024
GNSL
LETTER OF SUSPENSION E-MAILED
09/12/2024
CNSL
SUSPENSION LETTER WRITTEN
09/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/06/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/05/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
06/18/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
06/18/2024
CNSI
SUSPENSION INQUIRY WRITTEN
06/18/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/15/2023
GNSL
LETTER OF SUSPENSION E-MAILED
12/15/2023
CNSL
SUSPENSION LETTER WRITTEN
12/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/01/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/17/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/17/2023
CNSI
SUSPENSION INQUIRY WRITTEN
09/17/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/13/2023
GNSL
LETTER OF SUSPENSION E-MAILED
03/13/2023
CNSL
SUSPENSION LETTER WRITTEN
03/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/13/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/13/2023
ALIE
ASSIGNED TO LIE
03/10/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/03/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/07/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/07/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/07/2022
CNSI
SUSPENSION INQUIRY WRITTEN
09/07/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/07/2022
GNSL
LETTER OF SUSPENSION E-MAILED
03/07/2022
CNSL
SUSPENSION LETTER WRITTEN
03/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/16/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/16/2022
ALIE
ASSIGNED TO LIE
02/16/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/11/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/16/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/16/2021
CNSI
SUSPENSION INQUIRY WRITTEN
08/16/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/11/2021
GNSL
LETTER OF SUSPENSION E-MAILED
02/11/2021
CNSL
SUSPENSION LETTER WRITTEN
02/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/14/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/13/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/13/2021
GAUN
NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
01/13/2021
GAUD
NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
01/13/2021
NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
01/13/2021
DPCC
DIVISIONAL PROCESSING COMPLETE
11/23/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/23/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/12/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/12/2020
IROA
RESPONSE TO ITU OFFICE ACTION ENTERED
11/12/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
11/12/2020
INCD
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
11/04/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/04/2020
DRRR
DIVISIONAL REQUEST RECEIVED
09/23/2020
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
09/23/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/13/2020
GNRT
NON-FINAL ACTION E-MAILED
05/13/2020
CNRT
NON-FINAL ACTION WRITTEN
05/13/2020
DOCK
ASSIGNED TO EXAMINER
05/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/24/2020
NWAP
NEW APPLICATION ENTERED
02/22/2020
Continuous trademark protection
Get notified about every new filing that threatens MEDLIOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.